R&D
Partner Content
5th TCR-based Therapies for Solid Tumors Summit
In the midst of Immunocore's pioneering TCR bispecific product …
19746 items found
Digital
First impressions matter: Why getting your onboarding right is key for digital engagement
The pharmaceutical industry, with its stringent regulations, demands …
News
Keytruda improves survival in early-stage kidney cancer
MSD’s Keytruda has become the first checkpoint inhibitor to show …
News
BMS' subcutaneous Opdivo clears first phase 3 trial
Bristol-Myers Squibb is getting closer to offering a subcutaneous …
News
CHMP turns down Neuraxpharm, Apellis drugs
The EMA’s human medicines committee refused marketing approvals for …
R&D
Partner Content
R&D
Partner Content
Polymer Chemistry & Formulation in Drug Delivery
The increased prevalence of chronic diseases such as cancer, …
News
Then there were two: ArriVent set to list after $175m IPO
ArriVent BioPharma was beaten to the first biotech initial public …
R&D
JP Morgan 2024 – Frank Gleeson
In this brief dispatch from JP Morgan, editor-in-chief Jonah Comstock …
R&D
Partner Content
Pre-Filled Syringes and Injectable Drug Devices East Coast Conference and Exhibition
April 22 – 24, 2024 | Boston, USA www.pfsamericas.com/PharmaPhorum-Eve …
News
Britain will be first to get new Mounjaro device, says Lilly
Eli Lilly is just weeks away from launching Mounjaro in the UK, after …
News
AbbVie invests $223m in Singapore biologics site
AbbVie has broken ground on a new $223 million expansion of its …
Digital
A journey from personal to public: Digital health passports ...
A digital health passport is an app, or online certification, that displays a traveller’s health or vaccination record. It can save lives, on both private and public levels.
Sales & Marketing
Enabling site success: Key insights to reducing burden and i...
Investigator sites are essential for successful execution of clinical trials – ensuring studies are conducted ethically, safely, and in compliance with regulatory standards.
Sales & Marketing
Deep Dive: Commercialisation 2024
In this issue, we unpack Ozempic’s rise to superstar status and the risks associated with its off-label use.
Digital
Sponsored
How to deal with fragmented data - A $12.9 million challenge
In the age of AI, large data sets – like the treasure trove of customer data most biopharma companies are sitting on – are an invaluable asset.
R&D
LSX 2024 - Dr Tadaaki Taniguchi
At LSX in Boston last month, editor-in-chief Jonah Comstock caught up with Dr Tadaaki Taniguchi, chief medical officer at Astellas Pharmaceuticals to talk a bit about the company and some r
Sales & Marketing
Sponsored
Launch Excellence: Moments of Truth
The launch environment for pharmaceutical industry products is evolving at pace with new scientific discoveries and shifting engagement patterns, creating challenges and opportunities.
R&D
Partner Content
Less than three weeks away: Join Global Experts at Transderm...
11-12 November 2024 in London, UK
R&D
Partner Content
4th mRNA Analytical Development & Quality Control Summit | F...
Excitement for mRNA therapeutics continues, as RNA technologies are awarded the Nobel Prize for the second year running.
